| Teen To Graduate, Despite Fatal Disease |
|
|
|
| Wednesday, 09 June 2010 08:37 |
|
A rare and life threatening medical disorder has kept a Portsmouth teen out of school and unable to walk for months, but Wednesday night he will walk the stage at his graduation. Wednesday night, families will be filing into the N-Telos pavilion in Portsmouth to celebrate the graduation of Churchland High School's class of 2010, and all they've accomplished over the past four years.
But what one student accomplished over the past four weeks might just leave them in awe. "I feel good that I'm still alive," said Jawuan Trotter, who was diagnosed with Scleroderma. While his Churchland classmates have been busy planning new lives, in January Jawuan Trotter was planning for his death. "I was thinking of my own will in my head; it was a hard time," he said. It was almost unimaginable for the confident teen, who was voted homecoming prince. "We started to notice his hands became very thick and leather like," said Jawuan's mother Desiree Trotter. His doctor diagnosed him with Scleroderma. "We had never heard of it," his mother said. "We didn't know what it was, didn't know how to spell it, but she asked us not to look online, because Scleroderma is often deadly and rarely diagnosed in children. "I think this may be the first patient we've had on our inpatient rehab unit," said Dr. Jean Shelton. She says Scleroderma is an auto-immune disorder; Jawuan's immune system is essentially attacking his own body. "In his case, [the disease] attacks the brain, the spinal chord, as well as the soft tissues, the hands and the arms and throughout the body," Shelton said. It got so bad, Jawuan could not stand for more than five seconds. "When I couldn't go to school anymore it was depressing, very depressing," said Jawuan. He started working with therapists at Children's Hospital of the King's Daughters in April. But come Wednesday, it'ill be worth it. "He's graduating with a 3.38 advanced honors diploma," said Desiree Trotter. "That's awesome." Source: Wavy.com |
More articles :
» arGentis Continues To Expand
But arGentis grew its drug-development pipeline this month with the acquisition of the rights to a rheumatoid arthritis therapy from the - the terms of which, were not disclosed. The treatment was developed at the University of Tennessee Health...
» Unite Against Scleroderma
{gallery}unite{/gallery}
» Survival In Pulmonary Hypertension
Stephen C. Mathai, Laura K. Hummers, Hunter C. Champion, Fredrick M. Wigley, Ari Zaiman, Paul M. Hassoun, and Reda E. GirgisARTHRITIS & RHEUMATISMVol. 60, No. 2, February 2009, pp 569–577 DOI 10.1002/art.24267 © 2009, American College of...
» What are the Early Symptoms of Scleroderma?
Scleroderma is a term used to describe a group of rare, chronic diseases characterized by unusual tightening and hardening of the connective tissues and skin. There are two major types of : localized, which only affects the skin; and systemic, which...
» A Call For Better Monitoring and Treatment Of Scleroderma Patients
The New Zealand Scleroderma Group is calling for the introduction of a monitoring and treatment programme for New Zealanders with scleroderma to mark World Scleroderma Day on June 29.Scleroderma is an autoimmune connective tissue disease that can...
» Dermatomyositis
Dermatomyositis is one of a group of muscle diseases known as the inflammatory myopathies, which are characterized by chronic muscle inflammation accompanied by muscle weakness. Dermatomyositis’ cardinal symptom is a skin rash that precedes or...


